493280.KQ IMBiologics

Healthcare Biotechnology KOSDAQ
13,160 KRW
Close of Oct 30, 2026
12,700 104,000
Market cap
KRW 194B
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is 493280.KQ undervalued?

Graham number

The Graham number of IMBiologics cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

IMBiologics fundamental analysis

No fundamental analysis for IMBiologics yet.

IMBiologics stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About IMBiologics

IMBiologics Corp., a biotechnology company, engages in developing immunomodulatory antibody therapeutics to treat autoimmune diseases and cancer. The company uses Optimal Antibody Modality Manufacturing Technology (IM-OpDECon) for developing differentiated treatments for autoimmune diseases and immuno-oncology based on immuno-modulatory biologics. Its products include IMB-101, a bispecific therapeutic antibody that targets OX40L and TNF to modulate pathological immune mechan…

Full company profile